13.10.2022 - Dr. Andrea Small-Howard discusses the company s novel process for developing disease-specific, cannabinoid-based therapeutics.LAS VEGAS, Oct. 13, 2022 (GLOBE NEWSWIRE) - Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences . Seite 1